{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:26:46Z","timestamp":1787016406234,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1124\/jpet.122.001478","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T16:30:28Z","timestamp":1674232228000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats"],"prefix":"10.1016","volume":"385","author":[{"given":"Michael R.","family":"Chojnacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Thorndike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Partilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001478_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1471-4159.2011.07632.x","article-title":"Mephedrone, an abused psychoactive component of \u2018bath salts\u2019 and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum","volume":"120","author":"Angoa-P\u00e9rez","year":"2012","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.122.001478_bib2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001478_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001478_bib4","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","article-title":"Baths salts, spice, and related designer drugs: the science behind the headlines","volume":"34","author":"Baumann","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001478_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/164_2018_178","article-title":"Neuropharmacology of synthetic cathinones","volume":"252","author":"Baumann","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00213-018-5063-9","article-title":"The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes","volume":"236","author":"Blough","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001478_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/ml500113s","article-title":"Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics","volume":"5","author":"Blough","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/jpet.122.001478_bib8","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/bph.13030","article-title":"Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues","volume":"172","author":"Bonano","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.057307","article-title":"Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon","volume":"308","author":"Chadman","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001478_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1476-5381.1977.tb16752.x","article-title":"Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors","volume":"60","author":"Doxey","year":"1977","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI115135","article-title":"Effects of cocaine on excitation-contraction coupling of aortic smooth muscle from the ferret","volume":"87","author":"Egashira","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001478_bib12","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release","volume":"360","author":"Eshleman","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001478_bib14","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001478_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuropharm.2017.08.018","article-title":"Relative reinforcing effects of second-generation synthetic cathinones: acquisition of self-administration and fixed ratio dose-response curves in rats","volume":"134","author":"Gannon","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001478_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12987","article-title":"Behavioral effects of four novel synthetic cathinone analogs in rodents","volume":"26","author":"Gatch","year":"2021","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.122.001478_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00005344-197909000-00002","article-title":"Effects of prazosin and phentolamine on arterial pressure, heart rate, and renin activity: evidence in the conscious rat for the functional significance of the presynaptic alpha-receptor","volume":"1","author":"Graham","year":"1979","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib18","doi-asserted-by":"crossref","first-page":"e2621","DOI":"10.1002\/hup.2621","article-title":"Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone)","volume":"32","author":"Grifell","year":"2017","journal-title":"Hum Psychopharmacol"},{"key":"10.1124\/jpet.122.001478_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","article-title":"4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse","volume":"339","author":"Hadlock","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001478_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","article-title":"The cardiovascular effects of cocaine","volume":"70","author":"Havakuk","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.122.001478_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present--a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.122.001478_bib22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/emj.2010.096636","article-title":"Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service","volume":"28","author":"James","year":"2011","journal-title":"Emerg Med J"},{"key":"10.1124\/jpet.122.001478_bib23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.259390","article-title":"Newly developed dopamine D3 receptor antagonists, R-VK4-40 and R-VK4-116, do not potentiate cardiovascular effects of cocaine or oxycodone in rats","volume":"371","author":"Jordan","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001478_bib24","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","volume":"164","author":"Kehr","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib25","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/cn4001236","article-title":"\u201cDeconstruction\u201d of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter","volume":"4","author":"Kolanos","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.122.001478_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/FTD.0000000000000808","article-title":"A review of synthetic cathinone-related fatalities from 2017 to 2020","volume":"43","author":"La Maida","year":"2021","journal-title":"Ther Drug Monit"},{"key":"10.1124\/jpet.122.001478_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2012.04.021","article-title":"Mephedrone (\u2018bath salt\u2019) elicits conditioned place preference and dopamine-sensitive motor activation","volume":"126","author":"Lisek","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001478_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fphar.2019.00438","article-title":"Para-halogenation affects monoamine transporter inhibition properties and hepatocellular toxicity of amphetamines and methcathinones","volume":"10","author":"Luethi","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.122.001478_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2012.07.003","article-title":"Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone)","volume":"127","author":"Miller","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001478_bib31","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1124\/jpet.122.001478_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2016_18","article-title":"Decoding the structure of abuse potential for new psychoactive substances: structure-activity relationships for abuse-related effects of 4-substituted methcathinone analogs","volume":"32","author":"Negus","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/jpet.122.001478_bib33","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1038\/npp.2016.75","article-title":"Human pharmacology of mephedrone in comparison with MDMA","volume":"41","author":"Papaseit","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001478_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","article-title":"Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones","volume":"25","author":"Rickli","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.122.001478_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.103.053975","article-title":"In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates","volume":"307","author":"Rothman","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001478_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113778","article-title":"Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics","volume":"343","author":"Rudin","year":"2021","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.122.001478_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/npp.2014.325","article-title":"\u2018Second-generation\u2019 mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function","volume":"40","author":"Saha","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001478_bib38","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/bph.13043","article-title":"Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues","volume":"172","author":"Sakloth","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/jpet.120.000129","article-title":"Amphetamine-like neurochemical and cardiovascular effects of \u03b1-ethylphenethylamine analogs found in dietary supplements","volume":"376","author":"Schindler","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001478_bib40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.118.255976","article-title":"The supplement adulterant \u03b2-methylphenethylamine increases blood pressure by acting at peripheral norepinephrine transporters","volume":"369","author":"Schindler","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001478_bib41","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1111\/bph.13640","article-title":"Pharmacological mechanisms underlying the cardiovascular effects of the \u201cbath salt\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"173","author":"Schindler","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12842","article-title":"Stereoselective neurochemical, behavioral, and cardiovascular effects of alpha-pyrrolidinovalerophenone enantiomers in male rats","volume":"25","author":"Schindler","year":"2020","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.122.001478_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ehf2.12572","article-title":"Methamphetamine-related cardiovascular diseases","volume":"7","author":"Schwarzbach","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1124\/jpet.122.001478_bib44","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1476-5381.2012.02236.x","article-title":"Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia","volume":"168","author":"Shortall","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib45","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/adb.12283","article-title":"Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone","volume":"21","author":"Shortall","year":"2016","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.122.001478_bib46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001478_bib47","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s00204-021-03083-3","article-title":"An updated review on synthetic cathinones","volume":"95","author":"Soares","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.122.001478_bib48","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/npp.2017.98","article-title":"N-alkylated analogs of 4-methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability","volume":"42","author":"Solis","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.122.001478_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1124\/jpet.122.001478_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CN107559","article-title":"Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following \u201cbath salts\u201d injection","volume":"81","author":"Sutamtewagul","year":"2014","journal-title":"Clin Nephrol"},{"key":"10.1124\/jpet.122.001478_bib51","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11419-018-0427-8","article-title":"Blood concentrations of a new psychoactive substance 4-chloromethcathinone (4-CMC) determined in 15 forensic cases","volume":"36","author":"Tomczak","year":"2018","journal-title":"Forensic Toxicol"},{"key":"10.1124\/jpet.122.001478_bib52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00213-012-2855-1","article-title":"Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats","volume":"225","author":"Varner","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001478_bib53","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1523\/JNEUROSCI.4901-04.2006","article-title":"Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool","volume":"26","author":"Venton","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.122.001478_bib54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12640-020-00227-8","article-title":"Four synthetic cathinones: 3-chloromethcathinone, 4-chloromethcathinone, 4-fluoro-\u03b1-pyrrolidinopentiophenone, and 4-methoxy-\u03b1-pyrrolidinopentiophenone produce changes in the spontaneous locomotor activity and motor performance in mice with varied profiles","volume":"38","author":"Wojcieszak","year":"2020","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.122.001478_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12640-021-00329-x","article-title":"Behavioral effects of 4-CMC and 4-MeO-PVP in DBA\/2J mice after acute and intermittent administration and following withdrawal from intermittent 14-day treatment","volume":"39","author":"Wojcieszak","year":"2021","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.122.001478_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173128","article-title":"Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic cathinone derivatives in rats","volume":"203","author":"Xu","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.122.001478_bib57","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cells9040965","article-title":"Hyperthermia increases neurotoxicity associated with novel methcathinones","volume":"9","author":"Zhou","year":"2020","journal-title":"Cells"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:29:11Z","timestamp":1739953751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524004440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0022356524004440"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001478","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright.","name":"copyright","label":"Copyright"}]}}